COCRYSTAL PHARMA, INC. Financing Cash Flow
COCRYSTAL PHARMA, INC. (COCP) reported Financing Cash Flow of $5.37 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-03-31
- COCRYSTAL PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $1.03M.
- COCRYSTAL PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2023-12-31 was $0.00.
- COCRYSTAL PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2023-09-30 was $0.00.
- COCRYSTAL PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was $4.00M.
- COCRYSTAL PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2025 was $5.37M.
- COCRYSTAL PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2023 was $3.99M.
- COCRYSTAL PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$27.00K, a 100.07% decline from fiscal 2021.
- COCRYSTAL PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2021 was $38.47M, a 7.86% increase from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed | Net Cash Provided by (Used in) Financing Activities 87 month |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $5.37M 10-K · filed 2026-03-31 | |||||||
| 2025-09-30 | $4.34M 10-Q · filed 2025-11-14 | ||||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $4.00M derived: sum of 3 quarters · filed 2025-03-31 | $3.99M 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $4.00M derived: sum of 2 quarters · filed 2024-11-13 | $3.99M 10-Q · filed 2024-11-13 | $3.99M derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2023-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $3.99M 10-Q · filed 2024-08-14 | $3.99M derived: sum of 3 quarters · filed 2024-08-14 | $3.98M derived: sum of 4 quarters · filed 2024-08-14 | |||||
| 2023-03-31 | -$7.00K 10-Q · filed 2024-05-13 | -$14.00K derived: sum of 2 quarters · filed 2024-05-13 | -$21.00K derived: sum of 3 quarters · filed 2024-05-13 | -$28.00K derived: sum of 4 quarters · filed 2024-05-13 | |||||
| 2022-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$14.00K derived: sum of 2 quarters · filed 2024-03-28 | -$21.00K derived: sum of 3 quarters · filed 2024-03-28 | -$27.00K 10-K · filed 2024-03-28 | |||||
| 2022-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$14.00K derived: sum of 2 quarters · filed 2023-11-13 | -$20.00K 10-Q · filed 2023-11-13 | -$29.00K derived: sum of 4 quarters · filed 2023-11-13 | |||||
| 2022-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$13.00K 10-Q · filed 2023-08-14 | -$22.00K derived: sum of 3 quarters · filed 2023-08-14 | -$33.00K derived: sum of 4 quarters · filed 2023-08-14 | |||||
| 2022-03-31 | -$6.00K 10-Q · filed 2023-05-15 | -$15.00K derived: sum of 2 quarters · filed 2023-05-15 | -$26.00K derived: sum of 3 quarters · filed 2023-05-15 | $36.40M derived: sum of 4 quarters · filed 2023-05-15 | |||||
| 2021-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$20.00K derived: sum of 2 quarters · filed 2023-03-29 | $36.40M derived: sum of 3 quarters · filed 2023-03-29 | $38.47M 10-K · filed 2023-03-29 | |||||
| 2021-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $36.41M derived: sum of 2 quarters · filed 2022-11-14 | $38.48M 10-Q · filed 2022-11-14 | $42.09M derived: sum of 4 quarters · filed 2022-11-14 | |||||
| 2021-06-30 | $36.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $38.49M 10-Q · filed 2022-08-15 | $42.10M derived: sum of 3 quarters · filed 2022-08-15 | $57.64M derived: sum of 4 quarters · filed 2022-08-15 | |||||
| 2021-03-31 | $2.06M 10-Q · filed 2022-05-11 | $5.67M derived: sum of 2 quarters · filed 2022-05-11 | $21.22M derived: sum of 3 quarters · filed 2022-05-11 | $21.18M derived: sum of 4 quarters · filed 2022-05-11 | |||||
| 2020-12-31 | $3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $19.16M derived: sum of 2 quarters · filed 2022-03-23 | $19.11M derived: sum of 3 quarters · filed 2022-03-23 | $35.66M 10-K · filed 2022-03-23 | |||||
| 2020-09-30 | $15.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $15.50M derived: sum of 2 quarters · filed 2021-11-15 | $32.05M 10-Q · filed 2021-11-15 | $34.71M derived: sum of 4 quarters · filed 2021-11-15 | |||||
| 2020-06-30 | -$44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $16.50M 10-Q · filed 2021-08-16 | $19.16M derived: sum of 3 quarters · filed 2021-08-16 | $19.12M derived: sum of 4 quarters · filed 2021-08-16 | |||||
| 2020-03-31 | $16.55M 10-Q · filed 2021-05-17 | $19.20M derived: sum of 2 quarters · filed 2021-05-17 | $19.16M derived: sum of 3 quarters · filed 2021-05-17 | $19.10M derived: sum of 4 quarters · filed 2021-05-17 | |||||
| 2019-12-31 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $2.61M derived: sum of 2 quarters · filed 2021-03-17 | $2.55M derived: sum of 3 quarters · filed 2021-03-17 | $6.42M 10-K · filed 2021-03-17 | |||||
| 2019-09-30 | -$42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$107.00K derived: sum of 2 quarters · filed 2020-11-13 | $3.77M 10-Q · filed 2020-11-13 | $3.79M derived: sum of 4 quarters · filed 2020-11-13 | |||||
| 2019-06-30 | -$65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.81M 10-Q · filed 2020-08-06 | $3.83M derived: sum of 3 quarters · filed 2020-08-06 | $3.83M derived: sum of 4 quarters · filed 2020-08-06 | |||||
| 2019-03-31 | $3.88M 10-Q · filed 2020-05-13 | $3.90M derived: sum of 2 quarters · filed 2020-05-13 | $3.90M derived: sum of 3 quarters · filed 2020-05-13 | $11.59M derived: sum of 4 quarters · filed 2020-05-13 | |||||
| 2018-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $24.00K derived: sum of 2 quarters · filed 2020-03-27 | $7.71M derived: sum of 3 quarters · filed 2020-03-27 | $8.89M 10-K · filed 2020-03-27 | |||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $7.68M derived: sum of 2 quarters · filed 2019-11-12 | $8.87M 10-Q · filed 2019-11-12 | $9.87M derived: sum of 4 quarters · filed 2019-11-12 | |||||
| 2018-06-30 | $7.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $8.87M 10-Q · filed 2019-08-09 | $9.87M derived: sum of 3 quarters · filed 2019-08-09 | $9.95M derived: sum of 4 quarters · filed 2019-08-09 | |||||
| 2018-03-31 | $1.18M 10-Q · filed 2019-05-10 | $2.18M derived: sum of 2 quarters · filed 2019-05-10 | $2.26M derived: sum of 3 quarters · filed 2019-05-10 | ||||||
| 2017-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $1.08M derived: sum of 2 quarters · filed 2019-04-01 | $4.08M 10-K · filed 2019-04-01 | ||||||
| 2017-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $3.08M 10-Q · filed 2018-11-09 | |||||||
| 2017-06-30 | $3.00M 10-Q · filed 2018-08-09 | ||||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $4.01M derived: sum of 2 quarters · filed 2018-03-21 | $4.01M derived: sum of 3 quarters · filed 2018-03-21 | $9.02M 10-K · filed 2018-03-21 | |||||
| 2016-09-30 | $4.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $4.01M derived: sum of 2 quarters · filed 2017-11-08 | $9.02M 10-Q · filed 2017-11-08 | $9.02M derived: sum of 4 quarters · filed 2018-03-21 | |||||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $5.01M 10-Q · filed 2017-08-08 | $5.01M derived: sum of 3 quarters · filed 2018-03-21 | $5.01M derived: sum of 4 quarters · filed 2018-03-21 | |||||
| 2016-03-31 | $5.01M 10-Q · filed 2017-05-10 | $5.01M derived: sum of 2 quarters · filed 2018-03-21 | $5.01M derived: sum of 3 quarters · filed 2018-03-21 | $9.06M derived: sum of 4 quarters · filed 2018-03-21 | |||||
| 2015-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $3.00K derived: sum of 2 quarters · filed 2018-03-21 | $4.05M derived: sum of 3 quarters · filed 2018-03-21 | $15.88M 10-K · filed 2018-03-21 | |||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $4.05M derived: sum of 2 quarters · filed 2016-11-09 | $15.88M 10-Q · filed 2016-11-09 | $15.88M derived: sum of 4 quarters · filed 2017-03-31 | |||||
| 2015-06-30 | $4.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $15.88M 10-Q · filed 2016-08-09 | $15.88M derived: sum of 3 quarters · filed 2017-03-31 | $15.94M derived: sum of 4 quarters · filed 2017-03-31 | |||||
| 2015-03-31 | $11.83M 10-Q · filed 2016-05-10 | $11.83M derived: sum of 2 quarters · filed 2017-03-31 | $11.89M derived: sum of 3 quarters · filed 2017-03-31 | $11.93M derived: sum of 4 quarters · filed 2017-03-31 | |||||
| 2014-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $59.00K derived: sum of 2 quarters · filed 2017-03-31 | $97.00K derived: sum of 3 quarters · filed 2017-03-31 | $2.87M 10-K · filed 2017-03-31 | |||||
| 2014-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $96.00K derived: sum of 2 quarters · filed 2015-11-16 | $2.87M 10-Q · filed 2015-11-16 | $2.87M derived: sum of 4 quarters · filed 2015-11-16 | |||||
| 2014-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $2.81M 10-Q · filed 2015-08-14 | $2.81M derived: sum of 3 quarters · filed 2015-08-14 | $2.81M derived: sum of 4 quarters · filed 2015-08-14 | |||||
| 2014-03-31 | $2.77M 10-Q · filed 2015-05-14 | $2.77M derived: sum of 2 quarters · filed 2015-05-14 | $2.77M derived: sum of 3 quarters · filed 2015-05-14 | $2.77M derived: sum of 4 quarters · filed 2015-05-14 | $20.21M 10-Q · filed 2014-05-15 | ||||
| 2013-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $2.00K derived: sum of 2 quarters · filed 2015-03-31 | $3.00K derived: sum of 3 quarters · filed 2015-03-31 | $7.00K 10-K · filed 2015-03-31 | $5.15M 10-K · filed 2014-03-31 | ||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $1.00K derived: sum of 2 quarters · filed 2014-11-14 | $5.00K 10-Q · filed 2014-11-14 | $1.43M 10-Q · filed 2013-11-18 | $95.59K derived: sum of 4 quarters · filed 2014-11-14 | ||||
| 2013-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $5.00K 10-Q · filed 2014-08-14 | $919.87K 10-Q · filed 2013-08-15 | $95.59K derived: sum of 3 quarters · filed 2014-08-14 | -$354.74K derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | $4.00K 10-Q · filed 2014-05-15 | -$25.07K 10-Q · filed 2013-05-10 | $94.59K derived: sum of 2 quarters · filed 2014-05-15 | -$355.74K derived: sum of 3 quarters · filed 2014-05-15 | -$120.86K derived: sum of 4 quarters · filed 2014-05-15 | ||||
| 2012-12-31 | $90.59K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$359.74K derived: sum of 2 quarters · filed 2014-03-31 | -$124.86K derived: sum of 3 quarters · filed 2014-03-31 | $1.71M 10-K · filed 2014-03-31 | $1.49M 10-K · filed 2013-04-01 | ||||
| 2012-09-30 | -$450.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-18 | -$215.46K derived: sum of 2 quarters · filed 2013-11-18 | $1.62M 10-Q · filed 2013-11-18 | $2.06M derived: sum of 4 quarters · filed 2013-11-18 | |||||
| 2012-06-30 | $234.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-15 | $2.07M 10-Q · filed 2013-08-15 | $2.51M derived: sum of 3 quarters · filed 2013-08-15 | $786.82K derived: sum of 4 quarters · filed 2013-08-15 | |||||
| 2012-03-31 | $1.84M 10-Q · filed 2013-05-10 | $2.27M derived: sum of 2 quarters · filed 2013-05-10 | $551.94K derived: sum of 3 quarters · filed 2013-05-10 | -$61.25K derived: sum of 4 quarters · filed 2013-05-10 | |||||
| 2011-12-31 | $432.44K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | -$1.29M derived: sum of 2 quarters · filed 2013-04-01 | -$1.90M derived: sum of 3 quarters · filed 2013-04-01 | $575.52K 10-K · filed 2013-04-01 | |||||
| 2011-09-30 | -$1.72M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | -$2.33M derived: sum of 2 quarters · filed 2012-11-14 | $143.08K 10-Q · filed 2012-11-14 | $143.65K derived: sum of 4 quarters · filed 2012-11-14 | |||||
| 2011-06-30 | -$613.19K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2012-09-28 | $1.86M 10-Q/A · filed 2012-09-28 | $1.86M derived: sum of 3 quarters · filed 2012-10-02 | $2.00M derived: sum of 4 quarters · filed 2012-10-02 | |||||
| 2011-03-31 | $2.48M 10-Q/A · filed 2012-10-02 | $2.48M derived: sum of 2 quarters · filed 2012-10-02 | $2.61M derived: sum of 3 quarters · filed 2012-10-02 | ||||||
| 2010-12-31 | $563.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $134.48K derived: sum of 2 quarters · filed 2012-04-16 | $283.10K 10-K · filed 2012-04-16 | ||||||
| 2010-09-30 | $133.91K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $282.54K 10-Q · filed 2011-11-21 | |||||||
| 2010-06-30 | $148.62K 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |